6501 - 6525 of 8620 Results
Title
Year
-
OPENTitle: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 6Start Page: 1685End Page: 1696Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15307Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15307Citation Count: 97
-
OPENTitle: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's DiseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 6Start Page: 1831End Page: 1833Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15569Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15569Citation Count: 4
-
OPENTitle: European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapiesJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 9Start Page: 2580End Page: 2595Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15386Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15386Citation Count: 54
-
OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 12
-
OPENTitle: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cellsJournal Name: FEBS Open BioPublisher: WileyVol: 12Issue #: 5Start Page: 959End Page: 982Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.13398Best OA location URL: https://doi.org/10.1002/2211-5463.13398Citation Count: 7
-
RESTRICTEDTitle: Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of MedicineJournal Name: European Journal of NeurosciencePublisher: WileyVol: 55Issue #: 2Start Page: 350End Page: 353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15578Citation Count: 0
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 36
-
OPENTitle: Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 2Start Page: 632End Page: 645Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12684Best OA location URL: https://doi.org/10.1002/alz.12684Citation Count: 8
-
OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://escholarship.org/content/qt8nk3j1qr/qt8nk3j1qr.pdfCitation Count: 12
-
OPENTitle: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE studyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12263Best OA location URL: https://escholarship.org/content/qt6sd39197/qt6sd39197.pdfCitation Count: 12
-
OPENTitle: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discoveryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1889End Page: 1897Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12514Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12514Citation Count: 18
-
RESTRICTEDTitle: Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 6Start Page: 2618End Page: 2632Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12880Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11633037Citation Count: 15
-
OPENTitle: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potentialJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12274Citation Count: 25
-
OPENTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12243Citation Count: 11
-
OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://doi.org/10.1002/trc2.12329Citation Count: 16
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202216327Citation Count: 0
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202216327Citation Count: 0
- Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy2022OPENTitle: Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 4Start Page: 540End Page: 551Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51535Best OA location URL: https://doi.org/10.1002/acn3.51535Citation Count: 4
-
OPENTitle: Cognitive dysfunction 1 year after COVID‐19: evidence from eye trackingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 11Start Page: 1826End Page: 1831Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51675Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51675Citation Count: 9
-
OPENTitle: Clinical trajectories and biomarkers for weight variability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00362-3Best OA location URL: https://www.nature.com/articles/s41531-022-00362-3.pdfCitation Count: 15
-
OPENTitle: Plasma phosphorylated tau181 predicts cognitive and functional declineJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 1Start Page: 18End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51695Citation Count: 17
-
OPENTitle: Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00372-1Best OA location URL: https://www.nature.com/articles/s41531-022-00372-1.pdfCitation Count: 12
- Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy2022OPENTitle: Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00335-6Best OA location URL: https://www.nature.com/articles/s41531-022-00335-6.pdfCitation Count: 15
-
OPENTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 14
-
OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 8